Puma Biotechnology Financial Overview
Puma Biotechnology's market cap is currently $278.16M. The company's EPS TTM is $0.17; its P/E ratio is 7.55; Puma Biotechnology is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.19. See an overview of income statement, balance sheet, and cash flow financials.
